-
1دورية أكاديمية
المؤلفون: Grünwald, Viktor, Powles, Thomas, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, He, Cixin, Okpara, Chinyere E., McKenzie, Jodi, Choueiri, Toni K.
المساهمون: Grünwald, Viktor, Powles, Thoma, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Toma, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, He, Cixin, Okpara, Chinyere E., Mckenzie, Jodi, Choueiri, Toni K.
مصطلحات موضوعية: bone metastase, lenvatinib, liver metastase, lung metastase, pembrolizumab, renal cell carcinoma, sarcomatoid histology, sunitinib
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37664025; info:eu-repo/semantics/altIdentifier/wos/WOS:001059317200001; volume:13; firstpage:1223282; journal:FRONTIERS IN ONCOLOGY; https://hdl.handle.net/11586/464767Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85169664916
-
2دورية أكاديمية
المؤلفون: Grünwald, Viktor, Powles, Thomas, Kopyltsov, Evgeny, Kozlov, Vadim, Alonso-Gordoa, Teresa, Eto, Masatoshi, Hutson, Thomas, Motzer, Robert, Winquist, Eric, Maroto, Pablo, Keam, Bhumsuk, Procopio, Giuseppe, Wong, Shirley, Melichar, Bohuslav, Rolland, Frederic, Oya, Mototsugu, Rodriguez-Lopez, Karla, Saito, Kenichi, McKenzie, Jodi, Porta, Camillo
المساهمون: Grünwald, Viktor, Powles, Thoma, Kopyltsov, Evgeny, Kozlov, Vadim, Alonso-Gordoa, Teresa, Eto, Masatoshi, Hutson, Thoma, Motzer, Robert, Winquist, Eric, Maroto, Pablo, Keam, Bhumsuk, Procopio, Giuseppe, Wong, Shirley, Melichar, Bohuslav, Rolland, Frederic, Oya, Mototsugu, Rodriguez-Lopez, Karla, Saito, Kenichi, Mckenzie, Jodi, Porta, Camillo
مصطلحات موضوعية: Depth of response, Lenvatinib, Pembrolizumab, Renal cell carcinoma, Sunitinib
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36720658; info:eu-repo/semantics/altIdentifier/wos/WOS:001051202100001; journal:EUROPEAN UROLOGY ONCOLOGY; https://hdl.handle.net/11586/434871Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85166362238
-
3دورية أكاديمية
المؤلفون: Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, María J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K, CLEAR Trial Investigators
المساهمون: Gennigens, Christine
المصدر: New England Journal of Medicine, 384 (14), 1289 - 1300 (2021-04-08)
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Phenylurea Compounds, Programmed Cell Death 1 Receptor, Protein Kinase Inhibitors, Quinolines, Everolimus, pembrolizumab, lenvatinib, Sunitinib, Adult, Aged, 80 and over, Humanized/administration & dosage, Humanized/adverse effects, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Renal Cell/drug therapy, Renal Cell/mortality, Everolimus/administration & dosage, Everolimus/adverse effects, Female, Humans, Kidney Neoplasms/drug therapy, Kidney Neoplasms/mortality
العلاقة: urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/300816Test; info:hdl:2268/300816; scopus-id:2-s2.0-85103105017; info:pmid:33616314
